LSNE Contract Manufacturing is a CMO with a proven regulatory history specializing in a wide range of services including process development, fill/finish and lyophilization. LSNE has been providing cGMP services to the pharmaceutical, biotechnology and medical device industries since 1997. Through the thoughtful integration of three processing facilities, qualified staffing and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted material for clinical through commercial use.
With on-site development services, LSNE can partner with clients to optimize their current formulation and lyophilization cycle or develop a cycle from scratch and perform the necessary feasibility work. Once development activities are complete, LSNE can formulate, fill, lyophilize and package finished products. LSNE’s highly skilled personnel and automated equipment, work together to provide consistent, quality material. LSNE offers both the flexible approach commonly required with preclinical projects, as well as the cGMP framework necessary for late stage clinical and commercial manufacturing. Specializing in the production of high-quality small to medium size batches, LSNE is perfectly suited for orphan indications or products with modest annual volumes. LSNE’s experienced development, operations, quality and project management teams evaluate project objectives and recommend an optimal path forward to achieve easier regulatory submissions and a faster time to market. LSNE’s flexibility and responsiveness allow them to make their client’s batch a top priority so they can meet their client’s timelines and exceed their expectations. For more information, contact LSNE Contract Manufacturing at (603) 668-5763 or visit www.lyophilization.com.
With on-site development services, LSNE can partner with clients to optimize their current formulation and lyophilization cycle or develop a cycle from scratch and perform the necessary feasibility work. Once development activities are complete, LSNE can formulate, fill, lyophilize and package finished products. LSNE’s highly skilled personnel and automated equipment, work together to provide consistent, quality material. LSNE offers both the flexible approach commonly required with preclinical projects, as well as the cGMP framework necessary for late stage clinical and commercial manufacturing. Specializing in the production of high-quality small to medium size batches, LSNE is perfectly suited for orphan indications or products with modest annual volumes. LSNE’s experienced development, operations, quality and project management teams evaluate project objectives and recommend an optimal path forward to achieve easier regulatory submissions and a faster time to market. LSNE’s flexibility and responsiveness allow them to make their client’s batch a top priority so they can meet their client’s timelines and exceed their expectations. For more information, contact LSNE Contract Manufacturing at (603) 668-5763 or visit www.lyophilization.com.
Location: United States, New Hampshire, Bedford
Employees: 201-500
Phone: +1 603-668-5763
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Permira | permira.co... |
Mentions in press and media 4
| Date | Title | Description |
| 14.01.2021 | LSNE Expands Vial Fill Finish and Lyophilization Operations with New Automated Fill Line | |
| 27.08.2020 | LSNE-León Receives Approval From AEMPS To Manufacture Biotechnology Based Therapeutic Products | |
| 01.05.2017 | Term Sheet — Monday, May 1 | STARWOOD-IFICATION OF REAL ESTATE Increasingly, venture investors view real estate as the next industry to be transformed by disruptive technology. But as they start investing in the category, they might find that traditional real estate in... |
| 27.03.2017 | Term Sheet — Monday, March 27 | ET CETERA A smattering of news this morning… Paid Content You can't secure what you can't see From ExtraHop Equity Salvage: iHeart Media, the radio conglomerate that’s been owned by Bain Capital and Thomas H. Lee Partners for almost a decad... |